Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection
Deepak Tripathi, … , Vijaya Lakshmi Valluri, Ramakrishna Vankayalapati
Deepak Tripathi, … , Vijaya Lakshmi Valluri, Ramakrishna Vankayalapati
Published November 22, 2022
Citation Information: JCI Insight. 2022;7(22):e152357. https://doi.org/10.1172/jci.insight.152357.
View: Text | PDF
Research Article Immunology

Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection

  • Text
  • PDF
Abstract

To determine the mechanisms that mediate resistance to Mycobacterium tuberculosis (M. tuberculosis) infection in household contacts (HHCs) of patients with tuberculosis (TB), we followed 452 latent TB infection–negative (LTBI–) HHCs for 2 years. Those who remained LTBI– throughout the study were identified as nonconverters. At baseline, nonconverters had a higher percentage of CD14+ and CD3–CD56+CD27+CCR7+ memory-like natural killer (NK) cells. Using a whole-transcriptome and metabolomic approach, we identified deoxycorticosterone acetate as a metabolite with elevated concentrations in the plasma of nonconverters, and further studies showed that this metabolite enhanced glycolytic ATP flux in macrophages and restricted M. tuberculosis growth by enhancing antimicrobial peptide production through the expression of the surface receptor sialic acid binding Ig-like lectin–14. Another metabolite, 4-hydroxypyridine, from the plasma of nonconverters significantly enhanced the expansion of memory-like NK cells. Our findings demonstrate that increased levels of specific metabolites can regulate innate resistance against M. tuberculosis infection in HHCs of patients with TB who never develop LTBI or active TB.

Authors

Deepak Tripathi, Kamakshi Prudhula Devalraju, Venkata Sanjeev Kumar Neela, Tanmoy Mukherjee, Padmaja Paidipally, Rajesh Kumar Radhakrishnan, Igor Dozmorov, Abhinav Vankayalapati, Mohammad Soheb Ansari, Varalakshmi Mallidi, Anvesh Kumar Bogam, Karan P. Singh, Buka Samten, Vijaya Lakshmi Valluri, Ramakrishna Vankayalapati

×

Figure 2

Cytokine and chemokine production by PBMCs of nonconverters and converters at baseline (0 time point) and during follow-up (after 24 months).

Options: View larger image (or click on image) Download as PowerPoint
Cytokine and chemokine production by PBMCs of nonconverters and converte...
PBMCs were isolated from age-matched, epidemiological risk–matched, healthy (no comorbid conditions and no immunosuppressive drugs) converters (n = 16) and nonconverters (n = 16) at baseline (during the enrollment of study, when all participants were healthy and LTBI–) and after 24 months and cultured with or without ESAT-6 and CFP-10 (10 μg/mL each), as described in the Methods section. After 96 hours, the culture supernatants were collected, and the levels of the various chemokines and cytokines were measured using a multiplex ELISA. The P values were derived using repeated measures mixed-effects ANOVA followed by post hoc Tukey’s multiple comparisons test. Mean values and SEM are shown.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts